Workflow
KLOXXADO Nasal Spray 8 mg
icon
Search documents
Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™
Globenewswire· 2025-08-21 12:45
Core Insights - Emergent BioSolutions is collaborating with advocacy organizations to raise awareness about the dangers of fentanyl on National Fentanyl Prevention and Awareness Day, emphasizing the need for public education on opioid emergencies [1][2][3] - Synthetic opioids, particularly fentanyl, are responsible for nearly 70% of all overdose deaths in the U.S., highlighting the urgency of addressing this public health crisis [1] - The partnership aims to reduce stigma around opioid poisonings and promote the use of naloxone, a life-saving medication for opioid overdoses [1][3] Company Initiatives - Emergent BioSolutions is committed to public education through its Ready to Rescue initiative, which focuses on combating misinformation about opioid poisonings and encouraging the public to carry naloxone [3] - The company is expanding access to naloxone products, including over-the-counter NARCAN Nasal Spray 4 mg and prescription KLOXXADO Nasal Spray 8 mg, to ensure preparedness in opioid emergencies [3] Industry Context - National Fentanyl Prevention and Awareness Day serves as a platform for various stakeholders, including families, community leaders, and law enforcement, to unite against the fentanyl crisis [2] - The day emphasizes the distribution of naloxone and education on opioid overdose prevention, aiming to protect communities from the risks associated with illicit fentanyl [2]
Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health
Globenewswire· 2025-05-01 21:07
Core Points - Emergent BioSolutions Inc. has entered a three-year agreement valued at approximately $65 million to supply NARCAN Nasal Spray to the Ontario Ministry of Health for the Ontario Naloxone Program [1] - The agreement aims to enhance access to NARCAN Nasal Spray, which is critical for reversing opioid overdoses, especially given the ongoing opioid crisis in Ontario [2][3] Company Overview - Emergent BioSolutions has been supplying NARCAN Nasal Spray to Ontario since 2018, demonstrating a long-term commitment to addressing opioid poisoning deaths in Canada [1][3] - The company emphasizes the importance of making life-saving medications available to individuals at risk of opioid overdose and their communities [3][4] Industry Context - From January to March 2025, Ontario reported 653 suspected drug-related fatalities, averaging 7 deaths per day, although there was a 30% decrease in overdose deaths compared to the same period in the previous year [2] - The Ontario Naloxone Program is crucial for providing access to naloxone, a life-saving medication, to those at risk of opioid overdose [4]